Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 46 recruiting now early-phase tilt

Chronic Kidney Diseases: early-phase trial registry

46 of 74 indexed Chronic Kidney Diseases trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #183 of 28,707 conditions by registered trial count.

74 US clinical trials · 46 currently recruiting · #183 of 28,707 conditions by registered trial count

Chronic Kidney Diseases: 74 US clinical trials tracked, 46 recruiting.

Chronic Kidney Diseases is the subject of 74 registered US clinical trials on ClinicalTrials.gov, 46 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 6 of these trials.

Enrollment posture brief

Registry condition chronic-kidney-diseases

OPEN 46 | RECR 62% | LATE 6 | EARLY 15 | RANK #183 | SPON 6

Nearest open-share peer: Advanced Breast Cancer (62% recruiting · 29 trials)

Chronic Kidney Diseases (thi…62%Anatomic Stage II Breast Can54.1%Chronic Myelomonocytic Leuke40.5%Anemia18.9%HIV Infection12.2%
Open-enrollment share among volume-matched conditions near Chronic Kidney Diseases

Chronic Kidney Diseases lists 46 open slots (62% of 74 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Kidney Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Kidney Diseases is recruiting above its size-band peers.

    46 of 74 indexed trials (62.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Chronic Kidney Diseases trials is spread across many organizations.

    Brigham and Women's Hospital accounts for 6 of 74 trials (8.1%). 53 distinct sponsors appear on at least one study for this condition label.

  3. Typical Chronic Kidney Diseases enrolment sits around 108 participants.

    Median target enrolment is 108 among the 74 trials that report a genuine target (sentinel values excluded). 35 of those (47.3%) plan for fewer than 100 participants.

  4. Chronic Kidney Diseases research is mostly interventional.

    59 interventional and 15 observational studies make up this index (79.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 17Phase 28Phase 31Phase 45

Open and recent trials

74 total, page 2 of 2

ACTIVE NOT RECRUITING NA 422 participants

Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication

State University of New York at Buffalo

NCT05154773

ACTIVE NOT RECRUITING NA 206 participants

APOL1 Genetic Testing Program for Living Donors

Northwestern University

NCT04910867

ACTIVE NOT RECRUITING NA 70 participants

Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)

University of Michigan

NCT06189807

ACTIVE NOT RECRUITING Phase 1 50 participants

Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia

Disc Medicine

NCT05745883

ACTIVE NOT RECRUITING Phase 4 30 participants

Ferric Citrate in ESRD Pilot Project

Sreedhar Mandayam

NCT03055598

ACTIVE NOT RECRUITING Phase 4 30 participants

Immunogenicity of HPV Vaccine in Transplant Recipients.

Medical College of Wisconsin

NCT05557370

ACTIVE NOT RECRUITING NA 25 participants

Developing Tools for Dialysis Decision Support

VA Palo Alto Health Care System

NCT06597279

ACTIVE NOT RECRUITING Phase 1 16 participants

Immunological Tolerance in Patients With Mismatched Kidney Transplants

University of California, Los Angeles

NCT05806749

ACTIVE NOT RECRUITING NA 13 participants

Evaluation of Increased Fruits and Vegetables Consumption in Chronic Kidney Disease

Nand Wadhwa

NCT05050110

COMPLETED NA 1,168 participants

System Interventions to Achieve Early and Equitable Transplants (STEPS) Study

Wake Forest University Health Sciences

NCT05014256

COMPLETED NA 999 participants

Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit

Geisinger Clinic

NCT03470701

COMPLETED 555 participants

World Trade Center Kidney-Link

Icahn School of Medicine at Mount Sinai

NCT03234530

COMPLETED NA 222 participants

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions

Duke University

NCT03938324

COMPLETED NA 172 participants

Remote Physician Care for Home Hospital Patients

Brigham and Women's Hospital

NCT04080570

COMPLETED NA 153 participants

Supportive Understanding and Patient-centered Partnership for Optimizing Renal Treatment

University of Pennsylvania

NCT06378476

COMPLETED 78 participants

Sickle Cell Uric Acid (SCUA) - Cohort Repository

Virginia Commonwealth University

NCT04190888

COMPLETED 77 participants

Iron Deficiency and FGF23 Regulation in CKD and HF

Northwestern University

NCT03106298

COMPLETED NA 70 participants

Helping Empower Liver and Kidney Patients

Washington University School of Medicine

NCT03426787

COMPLETED NA 67 participants

Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management

3-C Institute for Social Development

NCT05630729

COMPLETED NA 63 participants

Activity Trackers for Improving BP

University of California, San Francisco

NCT03325426

COMPLETED NA 58 participants

Feasibility of Enhanced Dialysis Education (EDU) Intervention for Chronic Kidney Disease (CKD) Patients

University of Rochester

NCT03465449

COMPLETED NA 31 participants

Renal Effects of Melatonin Trial in Chronic Kidney Disease

University of Oklahoma

NCT04336566

COMPLETED NA 20 participants

Pilot to Examine Risk and Feasibility of Remote Management of BP From Childhood Into Early Adulthood

University of California, San Francisco

NCT03691701

COMPLETED NA 7 participants

Rural Home Hospital: Proof of Concept

Brigham and Women's Hospital

NCT04531280

← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 7
Phase 2 8
Phase 3 1
Phase 4 5

Named interventions

Most-linked intervention names on Chronic Kidney Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
7 trials
Placebo Other
3 trials
KidneyIntelX Diagnostic test
2 trials
Sham Training Device
2 trials
Ferric Citrate Drug
2 trials
Empagliflozin 10 MG Drug
2 trials
Mailed Urinalysis Smartphone Kit Other
1 trials
Trauma-Informed Care Training Other
1 trials

US sites by state

Facility locations filed on Chronic Kidney Diseases trials. A trial with sites in several states counts in each.

New York 15 trials
California 13 trials
Texas 9 trials
Massachusetts 9 trials
Pennsylvania 7 trials
North Carolina 7 trials
Florida 6 trials
Missouri 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Kidney Diseases page

74 registered trials, 46 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Kidney Diseases condition card totals 74 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.